Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (91-100 of 326) with videos related to

Pageof 33
Sort By:
Vaccines|August 9, 2020
Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCVMaría Q Marín, Kwinten Sliepen, Juan García-Arriaza, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 13, 2015
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimerLeopold Kong, Alba Torrents de la Peña, Marc C Deller, et al.
Elife|July 29, 2017
Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptideErik Lee Snapp, Nicholas McCaul, Matthias Quandte, et al.
Plos One|March 25, 2015
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individualsJorge Carrillo, Luis Manuel Molinos-Albert, Maria Luisa Rodríguez de la Concepción, et al.
Journal of Virology|March 4, 2026
Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylationTugba Atabey, Ronald Derking, Maddy L Newby, et al.
Virology|April 10, 2026
Isoform-dependent glycosylation of respiratory viral class I fusion glycoproteins by oligosaccharyltransferasesTugba Atabey, Maddy L Newby, Katina D Hulme, et al.
Plos One|May 24, 2013
Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsKatie Matthews, Nancy P Y Chung, Per Johan Klasse, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Retrovirology|September 28, 2015
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicityKwinten Sliepen, Gabriel Ozorowski, Judith A Burger, et al.
Journal of Virology|September 8, 2017
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP TrimersJonathan T Sullivan, Chidananda Sulli, Alberto Nilo, et al.
Pageof 33

Showing results (91-100 of 326) with videos related to

Sort By:
Pageof 33
Vaccines|August 9, 2020
Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCVMaría Q Marín, Kwinten Sliepen, Juan García-Arriaza, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 13, 2015
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimerLeopold Kong, Alba Torrents de la Peña, Marc C Deller, et al.
Elife|July 29, 2017
Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptideErik Lee Snapp, Nicholas McCaul, Matthias Quandte, et al.
Plos One|March 25, 2015
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individualsJorge Carrillo, Luis Manuel Molinos-Albert, Maria Luisa Rodríguez de la Concepción, et al.
Journal of Virology|March 4, 2026
Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylationTugba Atabey, Ronald Derking, Maddy L Newby, et al.
Virology|April 10, 2026
Isoform-dependent glycosylation of respiratory viral class I fusion glycoproteins by oligosaccharyltransferasesTugba Atabey, Maddy L Newby, Katina D Hulme, et al.
Plos One|May 24, 2013
Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsKatie Matthews, Nancy P Y Chung, Per Johan Klasse, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Retrovirology|September 28, 2015
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicityKwinten Sliepen, Gabriel Ozorowski, Judith A Burger, et al.
Journal of Virology|September 8, 2017
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP TrimersJonathan T Sullivan, Chidananda Sulli, Alberto Nilo, et al.
Pageof 33